All stock lists
Wave Life Sciences, Inc. (NASDAQ:WVE)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
3.17-0.01 (-0.16%)
Insider Score
––Not scored
WVE Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
WVE Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 2.27 M | 38.25 M | 17.25 M | 7.61 M | 8.70 M | 9.18 M |
| Revenue Growth (YoY) | -73.88 % | 316.85 % | -79.41 % | 199.11 % | -55.82 % | -26.82 % |
| Cost of Revenue | 0.00 | 0.00 | 2.26 M | 0.00 | 2.20 M | 2.16 M |
| Gross Profit | 2.27 M | 38.25 M | 14.98 M | 7.61 M | 6.50 M | 7.01 M |
| SG&A Expense | 24.78 M | 22.10 M | 20.90 M | 18.09 M | 17.99 M | 18.36 M |
| R&D Expense | 51.29 M | 47.44 M | 52.81 M | 45.87 M | 43.47 M | 40.62 M |
| Operating Expenses | 76.07 M | 69.54 M | 71.45 M | 63.96 M | 59.26 M | 56.81 M |
| Operating Income | -73.80 M | -31.30 M | -56.47 M | -56.35 M | -52.76 M | -49.80 M |
| Pretax Income | -69.36 M | -26.09 M | -53.18 M | -53.85 M | -50.47 M | -46.88 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -69.36 M | -26.09 M | -53.18 M | -53.85 M | -50.47 M | -46.88 M |
| EPS (Basic) | -0.34 | -0.13 | -0.30 | -0.32 | -0.31 | -0.29 |
| EPS (Diluted) | -0.34 | -0.13 | -0.30 | -0.32 | -0.31 | -0.29 |
| Shares Outstanding | 202.10 M | 200.17 M | 180.15 M | 167.74 M | 163.99 M | 162.53 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.